Carroll Financial Associates’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$19K Buy
588
+168
+40% +$5.23K ﹤0.01% 983
2021
Q3
$12K Sell
420
-20
-5% -$647 ﹤0.01% 1137
2021
Q2
$15K Buy
440
+398
+948% +$13.2K ﹤0.01% 1158
2021
Q1
$1K Hold
42
﹤0.01% 1550
2020
Q4
$1K Sell
42
-80
-66% -$1.9K ﹤0.01% 1441
2020
Q3
$2K Sell
122
-136
-53% -$2.62K ﹤0.01% 1317
2020
Q2
$3K Sell
258
-3
-1% -$38 ﹤0.01% 1276
2020
Q1
$2K Hold
261
﹤0.01% 1282
2019
Q4
$4K Sell
261
-620
-70% -$10.3K ﹤0.01% 1269
2019
Q3
$13K Sell
881
-400
-31% -$6.51K ﹤0.01% 926
2019
Q2
$30K Buy
1,281
+14
+1% +$413 ﹤0.01% 713
2019
Q1
$47K Buy
1,267
+40
+3% +$1.46K ﹤0.01% 581
2018
Q4
$39K Hold
1,227
﹤0.01% 527
2018
Q3
$48K Hold
1,227
0.01% 512
2018
Q2
$54K Buy
1,227
+8
+0.7% +$398 0.01% 483
2018
Q1
$59K Sell
1,219
-128
-10% -$6.4K 0.01% 464
2017
Q4
$67K Hold
1,347
0.01% 437
2017
Q3
$73K Buy
1,347
+92
+7% +$4.34K 0.01% 418
2017
Q2
$47K Hold
1,255
0.01% 509
2017
Q1
$48K Buy
1,255
+1,010
+412% +$30.4K 0.01% 482
2016
Q4
$5K Sell
245
-134
-35% -$2.75K ﹤0.01% 929
2016
Q3
$6K Buy
379
+120
+46% +$1.37K ﹤0.01% 907
2016
Q2
$2K Sell
259
-4,540
-95% -$40.5K ﹤0.01% 1044
2016
Q1
$33K Buy
4,799
+3,179
+196% +$16K 0.01% 499
2015
Q4
$8K Sell
1,620
-749
-32% -$4.79K ﹤0.01% 777
2015
Q3
$14K Buy
+2,369
New +$24.8K ﹤0.01% 639

Other funds holding CC

Carroll Financial Associates's CC Position: Q4 2021 in Review

Carroll Financial Associates increased its Chemours (CC) stake by 40% in Q4 2021, buying an estimated $5.23K and bringing the position to 588 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #983.

Carroll Financial Associates first reported a position in CC in Q3 2015 and has held it in 26 quarters since. The position peaked at $73K in Q3 2017. 504 funds tracked by Wall St. Rank hold CC as of Q4 2021.

  • Carroll Financial Associates held 588 shares of Chemours worth $19K as of Q4 2021.
  • Carroll Financial Associates bought 168 Chemours shares in Q4 2021, an estimated $5.23K.
  • Chemours made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #983 holding.
  • Carroll Financial Associates first reported a position in Chemours in Q3 2015 and has held it in 26 quarters since.
  • Carroll Financial Associates's Chemours position peaked at $73K in Q3 2017.
  • 504 funds tracked by Wall St. Rank held Chemours as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.